November 10, 2019 at 7:19 pm

Pacific Sun Financial Corp Sells 1,180 Shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

by

Pacific Sun Financial Corp cut its holdings in Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) by 10.5% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 10,072 shares of the company’s stock after selling 1,180 shares during the period. Pacific Sun Financial Corp’s holdings in Invesco Dynamic Pharmaceuticals ETF were worth $571,000 as of its most recent filing with the Securities & Exchange Commission.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Several other hedge funds have also added to or reduced their stakes in the company. Envestnet Asset Management Inc. grew its holdings in shares of Invesco Dynamic Pharmaceuticals ETF by 0.7% in the third quarter. Envestnet Asset Management Inc. now owns 188,064 shares of the company’s stock valued at $10,656,000 after acquiring an additional 1,357 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. grew its holdings in shares of Invesco Dynamic Pharmaceuticals ETF by 30.4% in the second quarter. Ladenburg Thalmann Financial Services Inc. now owns 14,582 shares of the company’s stock valued at $878,000 after acquiring an additional 3,402 shares in the last quarter. Peak Asset Management LLC grew its holdings in shares of Invesco Dynamic Pharmaceuticals ETF by 1.2% in the second quarter. Peak Asset Management LLC now owns 134,828 shares of the company’s stock valued at $8,111,000 after acquiring an additional 1,659 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Invesco Dynamic Pharmaceuticals ETF by 8.9% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 19,404 shares of the company’s stock valued at $1,167,000 after acquiring an additional 1,585 shares in the last quarter. Finally, Citadel Advisors LLC grew its holdings in shares of Invesco Dynamic Pharmaceuticals ETF by 84.4% in the second quarter. Citadel Advisors LLC now owns 25,267 shares of the company’s stock valued at $1,520,000 after acquiring an additional 11,565 shares in the last quarter.

Shares of PJP stock traded up $0.77 during trading on Friday, hitting $60.25. The company’s stock had a trading volume of 15,151 shares, compared to its average volume of 35,232. The business has a fifty day moving average of $57.71 and a 200-day moving average of $58.62. Invesco Dynamic Pharmaceuticals ETF has a 52 week low of $54.86 and a 52 week high of $70.89.

Invesco Dynamic Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.

Further Reading: Is the Dow Jones Industrial Average (DJIA) still relevant?

Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP).

Institutional Ownership by Quarter for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Leave a Comment

Your email address will not be published. Required fields are marked *